Inactive Instrument

News Egalet Corp Nasdaq

Equities

US28226B1044

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

ZYLA LIFE SCIENCES : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	20-05-20	AQ
ZYLA LIFE SCIENCES : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements (form 8-K)	20-05-20	AQ
Zyla Life Sciences Repaid All Outstanding Indebtedness and Terminated the Commitment Under its Revolving Credit Agreement	20-05-20	CI
Assertio and Zyla Life Sciences Announces Board Appointments to Combined Company	20-05-20	CI
Assertio Therapeutics, Inc. completed the acquisition of Zyla Life Sciences.	20-05-19	CI
Transcript : Zyla Life Sciences - Shareholder/Analyst Call	20-05-19
ZYLA LIFE SCIENCES : Other Events, Financial Statements and Exhibits (form 8-K)	20-05-15	AQ
Transcript : Zyla Life Sciences, Q1 2020 Earnings Call, May 15, 2020	20-05-15
ZYLA LIFE SCIENCES : Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits (form 8-K)	20-05-15	AQ
ZYLA LIFE SCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	20-05-14	AQ
Zyla Life Sciences Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-14	CI
Zyla Life Sciences : to Host Conference Call and Webcast to Discuss First Quarter 2020 Financial Results on May 15, 2020	20-05-01	PR
Zyla Life Sciences : Assertio Therapeutics Announces its Virtual 2020 Annual Meeting on May 19, 2020, and Mailing of its Joint Proxy Statement/Prospectus	20-04-20	AQ
ZYLA LIFE SCIENCES : Change in Directors or Principal Officers, Other Events (form 8-K)	20-04-13	AQ
Transcript : Zyla Life Sciences, 2019 Earnings Call, Mar 27, 2020	20-03-27
ZYLA LIFE SCIENCES : Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits (form 8-K)	20-03-27	AQ
ZYLA LIFE SCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	20-03-26	AQ
Zyla Life Sciences Reports Earnings Results for the Full Year Ended December 31, 2019	20-03-26	CI
Zyla Life Sciences Auditor Raises 'Going Concern' Doubt	20-03-25	CI
Zyla Life Sciences and Assertio Therapeutics Announce Management Appointments	20-03-17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Egalet Corp Nasdaq

Equities

US28226B1044

Summary

Filters